XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Shareholders Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance at Dec. 31, 2019 $ 9,367.6 $ 3.8 $ 858.4 $ 9,921.5 $ (1,598.2) $ 182.1
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2019   378,800,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) (797.1)     (203.0) (585.8) (8.3)
Stock Issued During Period, Shares, Restricted Stock Award, Gross   200,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (2.4)   (2.4)      
Stock based compensation (8.3)   (8.3)      
Dividends 0.2     0.2    
Dividends for noncontrolling interests (0.1)         (0.1)
Ending balance at Mar. 31, 2020 8,559.9 $ 3.8 847.7 9,718.7 (2,184.0) 173.7
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2020   379,000,000.0        
Beginning balance at Dec. 31, 2020 $ 9,755.2 $ 3.8 872.8 10,511.0 (1,806.2) 173.8
Common stock shares outstanding, beginning balance (in shares) at Dec. 31, 2020 378,764,442 379,100,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total comprehensive income (loss) $ 38.6     156.7 (117.3) (0.8)
Stock Issued During Period, Shares, Restricted Stock Award, Gross   600,000        
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (7.6)   (7.6)      
Stock based compensation 11.0   11.0      
Dividends for noncontrolling interests (0.2)         (0.2)
Ending balance at Mar. 31, 2021 $ 9,797.0 $ 3.8 $ 876.2 $ 10,667.7 $ (1,923.5) $ 172.8
Common stock shares outstanding, ending balance (in shares) at Mar. 31, 2021 379,090,013 379,700,000